
RARE vs RAPP
$RARE vs $RAPP head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
RARE vs RAPP: the quick read
- ·RAPP is the larger company by market cap ($1.54B vs $1.50B).
- ·RARE has been more active on our scanner (205 vs 67 alerts in 30 days).
- ·RAPP has the smaller float (39.9M vs 98.0M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (PHARMACEUTICAL PREPARATIONS vs Pharmaceutical Preparations), so they answer to different catalysts and a move in one says little about the other.
- ·RARE draws far more of our scanner's attention, 205 unusual-volume alerts in 30 days against 67, so it is the more actively traded of the two by some distance.
- ·They are closely matched in size, within 3% of each other on market cap, which makes the rest of this table the interesting part.
- ·They are pulling apart today: RAPP is outperforming the other by roughly 5.4 percentage points on the session.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing RARE and RAPP on TheDesperateTrader.
- Is RARE or RAPP the better stock?
- "Better" depends on your goal, and these two are not alike. RAPP is the larger company by market cap ($1.54B vs $1.50B). RARE has been more active on our scanner (205 vs 67 alerts in 30 days). RAPP has the smaller float (39.9M vs 98.0M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between RARE and RAPP?
- The differences that matter: they are not in the same business - RARE is pharmaceutical preparations and RAPP is pharmaceutical preparations; they are similar in size ($1.50B vs $1.54B); they trade at very different share prices ($14.70 vs $32.80); RARE sits at 7% of its 52-week range against 31% for RAPP; our scanner flagged RARE 205 times in the last 30 days against 67 for RAPP. Everything above is measured from the latest completed session and SEC filings.
- Which of RARE and RAPP is more active right now?
- Right now RARE is at about 0.7x its normal volume and RAPP is at about 0.6x, so RARE is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading RARE or RAPP? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore RARE and RAPP comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.